The Senescense Accelerated Mouse - Prone 8 (SAMP8) model is now available globally including in North America.
Envigo's sites in Bresso, Italy and Wyton, UK join the company's AAALAC accredited facilities.
Envigo announced today that its Board of Directors has appointed Dr Adrian Hardy as President and Chief Executive Officer, effective July 1, 2016. Brian Cass, the previous CEO, will become Executive Chairman.
Ms. Henahan has extensive financial experience in the life sciences sector, including leadership roles at Eli Lilly, AstraZeneca, MedImmune and Hospira.
Scott Schulz's appointment is set to further enhance efficiency, performance and best practice across Envigo's North American RMS operations -- optimising high quality service delivery
In order to provide you with a more customized experiencewhen viewing our models please select your location:
Copyright © 2016 Envigo